QuantaBrain Company
QuantaBrain has developed a novel and patented deep learning architecture capable of extracting neurofunctional biomarkers for 11 distinct neuropsychiatric conditions from just 2 minutes of resting-state functional MRI. By collecting pre- and post-treatment rs-fMRI data during Phase I trials, the model can be fine-tuned to predict individual responses to new compounds. This enables pharmaceutical companies to optimize their clinical trials through large-scale simulations of drug efficacy using internal data (prior to patient enrollment), enrichment strategies to select likely responders, and drug repurposing opportunities.
Pharma companies partnering with QuantaBrain can save up to $116M per approved drug.
Funding Status:
private
Last Funding Date:
2025-06-15
Headquarters:
Pisa,Toscana,Italy,Europe
Total Funding:
1028525
Founded Date:
2023-01-30
Industry:
Quantum Biology
Super Industry:
Quantum Science Applications
Funding Stage:
Seed
Funding Total Value:
925000
Last Funding Total Usd:
461980
Last Funding Total Currency:
EUR
Last Funding Total Value:
400000
Founders:
Elisa Ferrari,Pietro Carra
Phone Number:
+39 3391500442